» Articles » PMID: 19682525

Regional Brain Metabolism with Cytochrome C Oxidase Histochemistry in a PS1/A246E Mouse Model of Autosomal Dominant Alzheimer's Disease: Correlations with Behavior and Oxidative Stress

Overview
Journal Neurochem Int
Specialties Chemistry
Neurology
Date 2009 Aug 18
PMID 19682525
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondrial dysfunction and brain metabolic alteration are early neurofunctional aspects in Alzheimer's disease (AD). Regional brain metabolism was analyzed by cytochrome c oxidase (COX) histochemistry in PS1-A246E mouse mutants, a model of autosomal dominant AD overexpressing beta-amyloid (Abeta) peptide without amyloidosis or cell degeneration. Immunohistochemical samples were analyzed on adjacent sections for regional Abeta1-42 levels, as well as DNA oxidative damage with 8-hydroxy-2-deoxyguanosine (8-OHdG). COX activity increased in the basal forebrain nuclear complex, specific parts of the amygdala and hippocampus, as well as in striatum and connected regions. On the contrary, a hypometabolism was observed in midline thalamic, interpeduncular, and pedonculopontine nuclei. The integration of these regions in circuitries subserving emotions, arousal, and cognitive functions may explain why neurochemical alterations in specific brain regions were linearly correlated with psychomotor slowing and disinhibition previously reported in the mutant. As the PS1-A246E model appears to mimick prodromal AD, the results support the existence of mitochondrial abnormalities prior to AD-related cognitive deficits. However, since affected PS1-A246E brain regions were not primarily those altered in AD-associated histopathological features and did not systematically display either Abeta overexpression or higher 8-OHdG immunolabelling, the hypermetabolism observed seems to comprise a compensatory reaction to early mitochondrial abnormalities; furthermore, neuronal synaptic function should be considered as particularly relevant in COX activity changes.

Citing Articles

Inhibiting mtDNA transcript translation alters Alzheimer's disease-associated biology.

Gabrielli A, Novikova L, Ranjan A, Wang X, Ernst N, Abeykoon D Alzheimers Dement. 2024; 20(12):8429-8443.

PMID: 39441557 PMC: 11667520. DOI: 10.1002/alz.14275.


Basal forebrain volume and metabolism in carriers of the Colombian mutation for autosomal dominant Alzheimer's disease.

Teipel S, Grazia A, Dyrba M, Grothe M, Pomara N Sci Rep. 2024; 14(1):11268.

PMID: 38760448 PMC: 11101449. DOI: 10.1038/s41598-024-60799-9.


Mitochondria-sequestered Aβ renders synaptic mitochondria vulnerable in the elderly with a risk of Alzheimer disease.

Jia K, Tian J, Wang T, Guo L, Xuan Z, Swerdlow R JCI Insight. 2023; 8(22).

PMID: 37991017 PMC: 10721326. DOI: 10.1172/jci.insight.174290.


Time Course of Neurobehavioral Disruptions and Regional Brain Metabolism Changes in the Rotenone Mice Model of Parkinson's Disease.

Troshev D, Voronkov D, Pavlova A, Abaimov D, Latanov A, Fedorova T Biomedicines. 2022; 10(2).

PMID: 35203675 PMC: 8962442. DOI: 10.3390/biomedicines10020466.


COX5A Plays a Vital Role in Memory Impairment Associated With Brain Aging the BDNF/ERK1/2 Signaling Pathway.

Xiyang Y, Liu R, Wang X, Li S, Zhao Y, Lu B Front Aging Neurosci. 2020; 12:215.

PMID: 32754029 PMC: 7365906. DOI: 10.3389/fnagi.2020.00215.